An adenovirus based recombinant herpes simplex virus 2 (HSV-2) therapeutic vaccine is highly protective against acute and recurrent HSV-2 disease in a guinea pig model
Published: 7 September 2022| Version 1 | DOI: 10.17632/hd962mb4rh.1
Recombinant adenovirus-based vaccines including rAd-gD2ΔUL25, rAd-ΔUL25, and rAd-gD2 immunized guinea pig model. Humoral and cellular immune responses were described.
Immunity, Animal Protection